Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Lin Tseng

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Chinese Clinical Oncology|September 18, 2017
Postoperative stereotactic body radiotherapy for spinal metastasesMajed Alghamdi, Chia-Lin Tseng, Sten Myrehaug, et al.
International Journal of Radiation Oncology, Biology, Physics|February 20, 2026
Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac: UNITED trial Organs-at-Risk SparingThomas Mann, James Stewart, Amir H Safavi, et al.
Technology in Cancer Research & Treatment|September 8, 2022
Comparison of Prospectively Generated Glioma Treatment Plans Clinically Delivered on Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) Versus Conventional Linac: Predicted and Measured Skin DoseMichael H Wang, Anthony Kim, Mark Ruschin, et al.
Neuro-Oncology|August 15, 2019
Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastasesTimothy K Nguyen, Arjun Sahgal, Jay Detsky, et al.
Scientific Reports|July 7, 2025
Survival outcomes among patients with breast cancer and leptomeningeal diseaseBadr Id Said, Katarzyna J Jerzak, Hanbo Chen, et al.
Practical Radiation Oncology|March 30, 2023
Stereotactic Body Radiation Therapy for Posterior Element-Only Spinal Metastases: A First Report on Outcomes and Validation of Recommended Clinical Target Volume Delineation PracticeLaura Burgess, K Liang Zeng, Sten Myrehaug, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 11, 2022
Chemical Exchange Saturation Transfer MRI for Differentiating Radiation Necrosis From Tumor Progression in Brain Metastasis-Application in a Clinical SettingHatef Mehrabian, Rachel W Chan, Arjun Sahgal, et al.
Practical Radiation Oncology|March 16, 2020
Stereotactic Body Radiation Therapy for Nonspine Bone Metastases: International Practice Patterns to Guide Treatment PlanningTimothy K Nguyen, Arjun Sahgal, Roi Dagan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 28, 2020
Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trialMark Corkum, Andrew Loblaw, Yaser Hasan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2020
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 GyGerard Morton, Merrylee McGuffin, Hans T Chung, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Chinese Clinical Oncology|September 18, 2017
Postoperative stereotactic body radiotherapy for spinal metastasesMajed Alghamdi, Chia-Lin Tseng, Sten Myrehaug, et al.
International Journal of Radiation Oncology, Biology, Physics|February 20, 2026
Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac: UNITED trial Organs-at-Risk SparingThomas Mann, James Stewart, Amir H Safavi, et al.
Technology in Cancer Research & Treatment|September 8, 2022
Comparison of Prospectively Generated Glioma Treatment Plans Clinically Delivered on Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) Versus Conventional Linac: Predicted and Measured Skin DoseMichael H Wang, Anthony Kim, Mark Ruschin, et al.
Neuro-Oncology|August 15, 2019
Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastasesTimothy K Nguyen, Arjun Sahgal, Jay Detsky, et al.
Scientific Reports|July 7, 2025
Survival outcomes among patients with breast cancer and leptomeningeal diseaseBadr Id Said, Katarzyna J Jerzak, Hanbo Chen, et al.
Practical Radiation Oncology|March 30, 2023
Stereotactic Body Radiation Therapy for Posterior Element-Only Spinal Metastases: A First Report on Outcomes and Validation of Recommended Clinical Target Volume Delineation PracticeLaura Burgess, K Liang Zeng, Sten Myrehaug, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 11, 2022
Chemical Exchange Saturation Transfer MRI for Differentiating Radiation Necrosis From Tumor Progression in Brain Metastasis-Application in a Clinical SettingHatef Mehrabian, Rachel W Chan, Arjun Sahgal, et al.
Practical Radiation Oncology|March 16, 2020
Stereotactic Body Radiation Therapy for Nonspine Bone Metastases: International Practice Patterns to Guide Treatment PlanningTimothy K Nguyen, Arjun Sahgal, Roi Dagan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 28, 2020
Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trialMark Corkum, Andrew Loblaw, Yaser Hasan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2020
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 GyGerard Morton, Merrylee McGuffin, Hans T Chung, et al.
Pageof 14